+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pulmonary Embolism"

Pulmonary Embolism Market Report 2025 - Product Thumbnail Image

Pulmonary Embolism Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Acute Ischemic Stroke Therapeutics Market Report 2024 - Product Thumbnail Image

Acute Ischemic Stroke Therapeutics Market Report 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Deep Vein Thrombosis Market Report 2025 - Product Thumbnail Image

Deep Vein Thrombosis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Perfusion Imaging Market - Product Thumbnail Image

Perfusion Imaging Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
Mastering Structural Heart Disease. Edition No. 1 - Product Thumbnail Image

Mastering Structural Heart Disease. Edition No. 1

  • Book
  • February 2023
  • 672 Pages
Loading Indicator

Pulmonary embolism (PE) is a medical condition in which a blood clot blocks one or more arteries in the lungs. It is a serious complication of deep vein thrombosis (DVT), a condition in which a blood clot forms in a deep vein, usually in the leg. PE is a major cause of death in cardiology, and is estimated to affect up to 600,000 people in the United States each year. Symptoms of PE include chest pain, shortness of breath, and coughing up blood. Diagnosis is typically made through imaging tests such as computed tomography (CT) scans or echocardiograms. Treatment typically involves anticoagulant medications to prevent further clotting, and in some cases, clot-dissolving medications or surgery. Companies in the Pulmonary Embolism market include Boehringer Ingelheim, Bayer, Daiichi Sankyo, Pfizer, and Bristol-Myers Squibb. Show Less Read more